<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Laminin-211 is a cell-<z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule that is strongly expressed in the basement membrane of skeletal muscle </plain></SENT>
<SENT sid="1" pm="."><plain>By binding to the cell surface receptors dystroglycan and integrin α7β1, laminin-211 is believed to protect the muscle fiber from damage under the constant stress of contractions, and to influence signal transmission events </plain></SENT>
<SENT sid="2" pm="."><plain>The importance of laminin-211 in skeletal muscle is evident from merosin-deficient <z:hpo ids='HP_0003741'>congenital muscular dystrophy</z:hpo> type 1A (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDC1A</z:e>), in which absence of the α2 chain of laminin-211 leads to skeletal muscle dysfunction </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDC1A</z:e> is the commonest form of <z:hpo ids='HP_0003741'>congenital muscular dystrophy</z:hpo> in the European population </plain></SENT>
<SENT sid="4" pm="."><plain>Severe <z:mp ids='MP_0004144'>hypotonia</z:mp>, <z:hpo ids='HP_0003323'>progressive muscle weakness</z:hpo> and <z:mp ids='MP_0005150'>wasting</z:mp>, <z:hpo ids='HP_0001371'>joint contractures</z:hpo> and consequent impeded motion characterize this incurable disorder, which causes great difficulty in daily life and often leads to premature <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Mice with laminin α2 chain deficiency have analogous phenotypes, and are reliable models for studies of disease mechanisms and potential therapeutic approaches </plain></SENT>
<SENT sid="6" pm="."><plain>In this review, we introduce laminin-211 and describe its structure, expression pattern in developing and adult muscle and its receptor interactions </plain></SENT>
<SENT sid="7" pm="."><plain>We will also discuss the molecular pathogenesis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDC1A</z:e> and advances toward the development of treatment </plain></SENT>
</text></document>